| Dr Mary Renee Maceli, PHARMD | |
|
2200 Sw Gage Blvd, Topeka, KS 66622-0001 | |
| (785) 350-3111 | |
| Not Available |
| Full Name | Dr Mary Renee Maceli |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacotherapy |
| Location | 2200 Sw Gage Blvd, Topeka, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821376369 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 113184 (Kansas) | Secondary |
| 1835P1200X | Pharmacist - Pharmacotherapy | 113184 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Renee Maceli, PHARMD 2741 Inverness Ct, Lawrence, KS 66047-1891 Ph: (785) 856-1716 | Dr Mary Renee Maceli, PHARMD 2200 Sw Gage Blvd, Topeka, KS 66622-0001 Ph: (785) 350-3111 |
News Archive
URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, David Olson, a global development consultant, examines what non-governmental organizations (NGOs) "want to get out of the G20 Mexico on an issue that is a priority to NGOs as well as the Mexican presidency of the G20 - 'enhancing food security and addressing commodity price volatility,' in the words of the Mexican government."
STD Med, Inc. is pleased to announce that it has received a second Certificate of Good Practices for Manufacturing of Class III Medical Devices from ANVISA, the Brazilian National Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria –ANVISA).
OncoGenex Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended June 30, 2010 and reviewed the Company's highlights for the second quarter of 2010.
Tests that can distinguish whether HIV-positive people are infected with a drug-resistant strain or a non-resistant strain allow patients to get the most effective treatment as quickly as possible. In the November edition of the Journal of Molecular Diagnostics, a team of Brown University researchers describes a new method that works faster and more sensitively in lab testing than the current standard technologies.
› Verified 2 days ago
Mr. Gary Kluczykowski, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1740 Sw Wanamaker Rd, Topeka, KS 66604 Phone: 785-273-4040 | |
Josh Lock, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2010 Se 29th St, Topeka, KS 66605 Phone: 785-267-0234 Fax: 785-274-0221 | |
Joshua Schmidt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 785-295-8050 | |
Patrick Budenbender Ii, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2951 Sw Wanamaker Rd, Topeka, KS 66614 Phone: 785-271-0764 | |
Cara M Clingenpeel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Topeka, KS 66622 Phone: 785-350-3111 Fax: 785-350-4520 | |
Chris Kneidel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 121 Se 6th Ave, Topeka, KS 66603 Phone: 877-232-4601 | |
Gregory Mccandless Gage Russell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3900 Sw 29th St, Topeka, KS 66614 Phone: 785-271-9981 |